Kelem Kassahun

2.8k total citations
41 papers, 1.7k citations indexed

About

Kelem Kassahun is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kelem Kassahun has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 13 papers in Molecular Biology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kelem Kassahun's work include Pharmacogenetics and Drug Metabolism (13 papers), Pharmacological Effects and Toxicity Studies (13 papers) and HIV/AIDS drug development and treatment (12 papers). Kelem Kassahun is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Pharmacological Effects and Toxicity Studies (13 papers) and HIV/AIDS drug development and treatment (12 papers). Kelem Kassahun collaborates with scholars based in United States and Canada. Kelem Kassahun's co-authors include Thomas A. Baillie, Ian McIntosh, Margaret R. Davis, Pei Hu, F. S. Abbott, Edward L. Mattiuz, Todd A. Gillespie, Bryan D Martin, George A. Doss and John A. Wagner and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Pharmaceutical Research.

In The Last Decade

Kelem Kassahun

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelem Kassahun United States	21	590	516	362	298	271	41	1.7k
Brian Granda United States	18	446 0.8×	640 1.2×	287 0.8×	261 0.9×	825 3.0×	26	1.9k
Su Duan United States	26	534 0.9×	1.6k 3.0×	386 1.1×	531 1.8×	761 2.8×	43	2.9k
Jan‐Olof Svensson Sweden	22	239 0.4×	438 0.8×	215 0.6×	221 0.7×	162 0.6×	40	1.5k
Gordon McKay Canada	17	436 0.7×	323 0.6×	127 0.4×	184 0.6×	169 0.6×	23	2.1k
Barbra H. Stewart United States	20	439 0.7×	211 0.4×	126 0.3×	317 1.1×	514 1.9×	38	1.6k
Toshiro Niwa Japan	27	452 0.8×	1.1k 2.1×	345 1.0×	220 0.7×	505 1.9×	98	2.2k
Cosette J. Serabjit‐Singh United States	24	883 1.5×	1.2k 2.3×	183 0.5×	463 1.6×	1.3k 4.7×	40	3.1k
Masayo Yamazaki Japan	20	435 0.7×	533 1.0×	257 0.7×	723 2.4×	1.2k 4.4×	33	2.0k
Elke Störmer Germany	17	168 0.3×	491 1.0×	152 0.4×	257 0.9×	425 1.6×	18	1.2k
Tawakol A. El‐Shourbagy United States	21	419 0.7×	113 0.2×	188 0.5×	177 0.6×	129 0.5×	47	1.6k

Countries citing papers authored by Kelem Kassahun

Since Specialization

Citations

This map shows the geographic impact of Kelem Kassahun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelem Kassahun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelem Kassahun more than expected).

Fields of papers citing papers by Kelem Kassahun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelem Kassahun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelem Kassahun. The network helps show where Kelem Kassahun may publish in the future.

Co-authorship network of co-authors of Kelem Kassahun

This figure shows the co-authorship network connecting the top 25 collaborators of Kelem Kassahun. A scholar is included among the top collaborators of Kelem Kassahun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelem Kassahun. Kelem Kassahun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nallani, Gopinath C., et al.. (2025). In vitro metabolic clearance of malathion in rats and humans. Toxicology in Vitro. 107. 106080–106080.

Boteju, Lakmal W., et al.. (2022). In Vitro and In Vivo Metabolism of a Novel Antimitochondrial Cancer Metabolism Agent, CPI-613, in Rat and Human. Drug Metabolism and Disposition. 50(4). 361–373. 7 indexed citations

Kassahun, Kelem, Ian McIntosh, Li Sun, et al.. (2014). Disposition and Metabolism of the Cathepsin K Inhibitor Odanacatib in Humans. Drug Metabolism and Disposition. 42(5). 818–827. 27 indexed citations

Kassahun, Kelem, W. Cameron Black, Deborah A. Nicoll‐Griffith, et al.. (2011). Pharmacokinetics and Metabolism in Rats, Dogs, and Monkeys of the Cathepsin K Inhibitor Odanacatib: Demethylation of a Methylsulfonyl Moiety as a Major Metabolic Pathway. Drug Metabolism and Disposition. 39(6). 1079–1087. 25 indexed citations

Brainard, Diana M., Kelem Kassahun, Larissa Wenning, et al.. (2010). Lack of a Clinically Meaningful Pharmacokinetic Effect of Rifabutin on Raltegravir: In Vitro/In Vivo Correlation. The Journal of Clinical Pharmacology. 51(6). 943–950. 29 indexed citations

Kumar, Sanjeev, Kaushik Mitra, Kelem Kassahun, & Thomas A. Baillie. (2009). Approaches for Minimizing Metabolic Activation of New Drug Candidates in Drug Discovery. Handbook of experimental pharmacology. 511–544. 16 indexed citations

Chu, Xiaoyan, Yuexia Liang, Xiaoxin Cai, et al.. (2008). Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters. Pharmaceutical Research. 26(2). 459–468. 16 indexed citations

Kassahun, Kelem, Ian McIntosh, Donghui Cui, et al.. (2007). Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme. Drug Metabolism and Disposition. 35(9). 1657–1663. 223 indexed citations

Iwamoto, Marian, Kelem Kassahun, Matthew D. Troyer, et al.. (2007). Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation. The Journal of Clinical Pharmacology. 48(2). 209–214. 70 indexed citations

10.

Kassahun, Kelem, Konstantine W. Skordos, Ian McIntosh, et al.. (2005). Zafirlukast Metabolism by Cytochrome P450 3A4 Produces an Electrophilic α,β-Unsaturated Iminium Species That Results in the Selective Mechanism-Based Inactivation of the Enzyme. Chemical Research in Toxicology. 18(9). 1427–1437. 48 indexed citations

11.

Mattiuz, Edward L., et al.. (2002). The Disposition, Metabolism, and Pharmacokinetics of a Selective Metabotropic Glutamate Receptor Agonist in Rats and Dogs. Drug Metabolism and Disposition. 30(1). 27–33. 19 indexed citations

12.

Baillie, Thomas A. & Kelem Kassahun. (2001). Biological Reactive Intermediates in Drug Discovery and Development. Advances in experimental medicine and biology. 500. 45–51. 16 indexed citations

13.

Tang, Cuyue, et al.. (2000). Simultaneous determination of urinary free cortisol and 6β-hydroxycortisol by liquid chromatography–atmospheric pressure chemical ionization tandem mass spectrometry and its application for estimating hepatic CYP3A induction. Journal of Chromatography B Biomedical Sciences and Applications. 742(2). 303–313. 31 indexed citations

14.

Macias, William L., et al.. (1998). Lack of Effect of Olanzapine on the Pharmacokinetics of a Single Aminophylline Dose in Healthy Men. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(6). 1237–1248. 11 indexed citations

15.

Baillie, Thomas A. & Kelem Kassahun. (1994). Reversibility in Glutathione-Conjugate Formation. Advances in pharmacology. 163–181. 28 indexed citations

16.

Kassahun, Kelem, Claudia M. Jochheim, & Thomas A. Baillie. (1994). Effect of carbamate thioester derivatives of methyl- and 2-chloroethyl isocyanate on glutathione levels and glutathione reductase activity in isolated rat hepatocytes. Biochemical Pharmacology. 48(3). 587–594. 17 indexed citations

17.

Davis, Margaret R., Kelem Kassahun, Claudia M. Jochheim, K. Brandt, & Thomas A. Baillie. (1993). Glutathione and N-acetylcysteine conjugates of 2-chloroethyl isocyanate. Identification as metabolites of N,N'-bis(2-chloroethyl)-N-nitrosourea in the rat and inhibitory properties toward glutathione reductase in vitro. Chemical Research in Toxicology. 6(3). 376–383. 43 indexed citations

18.

Kassahun, Kelem & F. S. Abbott. (1993). In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid.. Drug Metabolism and Disposition. 21(6). 1098–1106. 32 indexed citations

19.

Kassahun, Kelem & Thomas A. Baillie. (1993). Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations.. Drug Metabolism and Disposition. 21(2). 242–248. 26 indexed citations

20.

Baillie, Thomas A., Kelem Kassahun, Mark P. Grillo, et al.. (1992). Metabolic activation of unsaturated derivatives of valproic acid: role of microsomal versus mitochondrial enzyme systems. Journal of Basic and Clinical Physiology and Pharmacology. 3(Supplement). 68–69. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact